Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis
- PMID: 25909698
- PMCID: PMC4410427
- DOI: 10.1097/HJH.0000000000000500
Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis
Abstract
Background: Longitudinal associations between the aminoterminal pro-B-type natriuretic peptide (NT-proBNP) and incident hypertension are lacking.
Methods: We tested associations between baseline NT-proBNP (bNT-proBNP) and change in NT-proBNP (ΔNT-proBNP) (visit 3 NT-proBNP - bNT-proBNP, 3.2 years apart) with incident hypertension (SBP ≥ 140 and/or DBP ≥90 mmHg or taking antihypertensive medications). Incident hypertension was evaluated in 5596 individuals in the Multi-Ethnic Study of Atherosclerosis without hypertension at baseline (53% women, age range 45-84 years without overt cardiovascular disease) and follow-up for 9.5 years and in a subgroup (1550) who had bNT-proBNP less than 100 pg/ml and no hypertension at visit 3. Incident hypertension was regressed (proportional hazards) on quintiles of bNT-proBNP (range) (reference <19.2, 19.3-40.8, 40.9-70.9, 71-135.2, and >135.5) and also on ΔNT-proBNP categories (reference <-10, -10 to 10, >10 to 50, and >50 pg/ml). Hazard ratios were adjusted for age, race, sex, education, diabetes, obesity, left ventricle mass/height, SBP and DBP, interleukin-6, salt intake, estimated glomerular filtration rate, and exercise.
Results: Compared with the reference category, hazard ratios (95% confidence interval) for incident hypertension compared with the first quintile of bNT-proBNP were 1.47 (1.13-1.93), 1.57 (1.18-2.09), 1.52 (1.12-2.06), and 2.36 (1.62-3.41). Hazard ratios for incident hypertension by categories of ΔNT-proBNP from 3.2 to 9.5 years follow-up were 0.98 (0.62-1.56), 1.13 (0.72-1.79), and 1.82 (1.07-3.12).
Conclusion: The development of hypertension tended to be preceded by elevated levels of bNT-proBNP or a substantial positive ΔNT-proBNP.
Figures



Comment in
-
NT-proBNP and the risk of incident hypertension: is change over time a better predictor than baseline value?J Hypertens. 2015 May;33(5):924-5. doi: 10.1097/HJH.0000000000000571. J Hypertens. 2015. PMID: 25909693 No abstract available.
Similar articles
-
Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).Diabetes Metab. 2015 Nov;41(5):378-86. doi: 10.1016/j.diabet.2015.04.005. Epub 2015 Jun 3. Diabetes Metab. 2015. PMID: 26047677 Free PMC article.
-
Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.J Am Coll Cardiol. 2021 Feb 9;77(5):559-571. doi: 10.1016/j.jacc.2020.11.063. J Am Coll Cardiol. 2021. PMID: 33538254 Free PMC article.
-
N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.Circ Heart Fail. 2012 Nov;5(6):727-34. doi: 10.1161/CIRCHEARTFAILURE.112.968701. Epub 2012 Oct 2. Circ Heart Fail. 2012. PMID: 23032197 Free PMC article.
-
The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).Hypertension. 2014 Mar;63(3):507-13. doi: 10.1161/HYPERTENSIONAHA.113.02204. Epub 2013 Dec 9. Hypertension. 2014. PMID: 24324046 Clinical Trial.
-
N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.Heart. 2013 Dec;99(24):1832-6. doi: 10.1136/heartjnl-2013-304724. Epub 2013 Oct 16. Heart. 2013. PMID: 24131775
Cited by
-
The association between left ventricular mass index and serum sirtuin 3 level in patients with hypertension.Cardiovasc Endocrinol Metab. 2020 Aug 27;10(2):99-105. doi: 10.1097/XCE.0000000000000231. eCollection 2021 Jun. Cardiovasc Endocrinol Metab. 2020. PMID: 34113795 Free PMC article.
-
Cyclic guanosine monophosphate and 10-year change in left ventricular mass: the Multi-Ethnic Study of Atherosclerosis (MESA).Biomarkers. 2021 Jun;26(4):309-317. doi: 10.1080/1354750X.2021.1893811. Epub 2021 Mar 9. Biomarkers. 2021. PMID: 33715578 Free PMC article.
-
Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA).Hypertension. 2020 Feb;75(2):316-323. doi: 10.1161/HYPERTENSIONAHA.119.13952. Epub 2019 Dec 23. Hypertension. 2020. PMID: 31865797 Free PMC article.
-
Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.Biomolecules. 2020 Mar 4;10(3):394. doi: 10.3390/biom10030394. Biomolecules. 2020. PMID: 32143410 Free PMC article. Clinical Trial.
-
The Sleep Apnea-Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality.Am J Respir Crit Care Med. 2021 Jun 15;203(12):1546-1555. doi: 10.1164/rccm.202010-3900OC. Am J Respir Crit Care Med. 2021. PMID: 33406013 Free PMC article.
References
-
- Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. Journal of Human Hypertension. 1993;7 (3):245–250. - PubMed
-
- Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med. 1992;92 (1):29–34. - PubMed
-
- Freitag MH, Larson MG, Levy D, Benjamin EJ, Wang TJ, Leip EP, et al. Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension. 2003;41 (4):978–983. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL066075/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- N01-HC 9808/HC/NHLBI NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- R01-HL 66075/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC 95168/HC/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials